us optum de identified electronic health record dataset Search Results


us optum de identified electronic health record data set  (Optum Inc)
86
Optum Inc us optum de identified electronic health record data set
Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified <t>Electronic</t> Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors
Us Optum De Identified Electronic Health Record Data Set, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/us+optum+de+identified+electronic+health+record+dataset/electronic+health+records/pmc12317948-53-86-87
Average 86 stars, based on 1 article reviews
us optum de identified electronic health record data set - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
us optum de identified electronic health record dataset  (Optum Inc)
86
Optum Inc us optum de identified electronic health record dataset
Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified <t>Electronic</t> Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors
Us Optum De Identified Electronic Health Record Dataset, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/us+optum+de+identified+electronic+health+record+dataset/ehr+optum/pmc13267428-167-34-35
Average 86 stars, based on 1 article reviews
us optum de identified electronic health record dataset - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
optum clinformatics data mart  (Optum Inc)
86
Optum Inc optum clinformatics data mart
Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified <t>Electronic</t> Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors
Optum Clinformatics Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/us+optum+de+identified+electronic+health+record+dataset/clinformatics+data+database+mart/10__1016_slash_s0168___8278_ascii40_22_ascii41_00423___8-10415-6-6
Average 86 stars, based on 1 article reviews
optum clinformatics data mart - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified Electronic Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors

Journal: Diabetes Therapy

Article Title: Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease

doi: 10.1007/s13300-025-01750-7

Figure Lengend Snippet: Outcomes: Optum ® EHR. a Incidence rates of primary outcomes, SGLT2i cohort. b Cumulative incidence of secondary outcomes, SGLT2i cohort. c Incidence rates of primary outcomes, GLP-1 RA cohort. d Cumulative incidence of secondary outcomes, GLP-1 RA cohort. CI confidence internal, eGFR estimated glomerular filtration rate, GLP-1 RA glucagon-like peptide-1 receptor agonists, IR incidence rate, Optum® EHR Optum ® de-identified Electronic Health Record data set, SGLT2i sodium-glucose cotransporter 2 inhibitors

Article Snippet: This was a multidatabase, multinational cohort study aiming to describe the incidence of cardiorenal events in separate, non-mutually exclusive cohorts of patients with both CKD and T2D initiating therapy with either an SGLT2i or GLP-1 RA using secondary data from four participating data sources: two population-based data sources in Europe (Danish National Health Registers [DNHR] and Valencia Health System Integrated Database [VID] in Spain); one hospital-based CKD registry in Japan (Japan Chronic Kidney Disease Database Extension [J-CKD-DB-Ex]); and one electronic health record (EHR) database in the US (Optum ® de-identified Electronic Health Record data set [Optum ® EHR]).

Techniques: Filtration